How big is the Brain Implants Market?

The Brain Implants Market size is expected to reach USD 7.35 billion in 2024 and grow at a CAGR of 10.67% to reach USD 12.20 billion by 2029. Read More

What is the current Brain Implants Market size?

In 2024, the Brain Implants Market size is expected to reach USD 7.35 billion. Read More

Who are the key players in Brain Implants Market?

Boston Scientific Corporation, Medtronic PLC, NeuroPace Inc., Renishaw PLC and Abbott Laboratories are the major companies operating in the Brain Implants Market. Read More

Which is the fastest growing region in Brain Implants Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Brain Implants Market?

In 2024, the North America accounts for the largest market share in Brain Implants Market. Read More

What years does this Brain Implants Market cover, and what was the market size in 2023?

In 2023, the Brain Implants Market size was estimated at USD 6.64 billion. The report covers the Brain Implants Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Brain Implants Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Brain Implants Market - Share, Size & Insights

Brain Implants Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Brain Implants Market Dynamics and it is Segmented by Product Type (Deep Brain Stimulator, Spinal Cord Stimulator, and Vagus Nerve Stimulator), Application (Chronic Pain, Epilepsy, Parkinson's Disease, Depression, Essential Tremor, Alzheimer's Disease, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market Values are Provided in USD million for the Above-mentioned Segments.

Brain Implants Industry Overview

The brain implant market is moderately consolidated with the presence of a few key players. Some of the market players are Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, Medtronic PLC, NDI Medical PLC, NeuroPace Inc., NeuroSigma, Synchron Inc., and Renishaw PLC.